Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-24-049086
Filing Date
2024-04-26
Accepted
2024-04-26 16:05:14
Documents
11

Document Format Files

Seq Description Document Type Size
1 DEFA14A dvax-20240426.htm   iXBRL DEFA14A 30550
  Complete submission text file 0000950170-24-049086.txt   78908

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT dvax-20240426.xsd EX-101.SCH 7989
14 EXTRACTED XBRL INSTANCE DOCUMENT dvax-20240426_htm.xml XML 1487
Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-34207 | Film No.: 24883521
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)